The adverse effects of olutasidenib include cytopenias, acute liver injury and failure (ALT, AST, γ-GT), GI side effects, pneumonia, hypokalemia, differentiation syndrome, and tumor lysis syndrome. The gene discussed is GPT; the disease is susceptibility to pneumonia measurement.